Ketamine therapy startup Nue Life will offer its services to health systems, medical networks and prescribers in all 50 states through its new partnership program. Dubbed Nue Network, the program allows partners to provide patients with at-home ketamine treatment and integrated therapy programs. In addition to the medication, the program also gives patients access to […]
Category: Psychedelics
Yet another company that uses psychedelics to treat mental illness is moving into the U.S. market. In June, Vancouver, Canada-based Numinus Wellness (TSX: NUMI) expanded its geographic footprint into the U.S. with its acquisition of Novamind, a mental health company specializing in psychedelic medicine. Novamind is headquartered in Toronto, but its clinics are located in […]
Therapeutic ketamine providers are seeing growth and positive patient outcomes, but companies caution that the business requires guardrails as it expands. The drug ketamine was originally invented in the 1960’s as a surgical anesthetic for humans and animals. But ketamine’s dissociative and hallucinogenic properties meant people have also used it recreationally, and more recently, for […]
Public benefit corporation Osmind Inc. announced Tuesday it completed a $40 million Series B funding round. The San Francisco-based startup will use the funding to further develop its electronic health record (EHR) technology for mental health research and treatment, advance research with new partners, and double the size of its workforce, according to a news […]
Sign up
Receive industry updates and breaking news from Behavioral Health Business